- Home
- DDL vs CGEM Comparison
DDL vs CGEM Comparison
Compare DDL & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDL
- CGEM
- Stock Information
- Founded
- DDL 2014
- CGEM 2016
- Country
- DDL China
- CGEM United States
- Employees
- DDL N/A
- CGEM N/A
- Industry
- DDL Catalog/Specialty Distribution
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- DDL Consumer Discretionary
- CGEM Health Care
- Exchange
- DDL Nasdaq
- CGEM Nasdaq
- Market Cap
- DDL 457.4M
- CGEM 530.0M
- IPO Year
- DDL 2021
- CGEM 2021
- Fundamental
- Price
- DDL $2.00
- CGEM $7.67
- Analyst Decision
- DDL
- CGEM Strong Buy
- Analyst Count
- DDL 0
- CGEM 5
- Target Price
- DDL N/A
- CGEM $30.00
- AVG Volume (30 Days)
- DDL 636.2K
- CGEM 348.1K
- Earning Date
- DDL 08-06-2025
- CGEM 08-07-2025
- Dividend Yield
- DDL N/A
- CGEM N/A
- EPS Growth
- DDL N/A
- CGEM N/A
- EPS
- DDL 0.18
- CGEM N/A
- Revenue
- DDL $3,241,404,122.00
- CGEM N/A
- Revenue This Year
- DDL $8.80
- CGEM N/A
- Revenue Next Year
- DDL $11.75
- CGEM N/A
- P/E Ratio
- DDL $11.02
- CGEM N/A
- Revenue Growth
- DDL 17.62
- CGEM N/A
- 52 Week Low
- DDL $1.62
- CGEM $6.85
- 52 Week High
- DDL $4.79
- CGEM $21.01
- Technical
- Relative Strength Index (RSI)
- DDL 39.48
- CGEM 38.41
- Support Level
- DDL $2.01
- CGEM $8.47
- Resistance Level
- DDL $2.29
- CGEM $9.25
- Average True Range (ATR)
- DDL 0.08
- CGEM 0.45
- MACD
- DDL 0.01
- CGEM -0.12
- Stochastic Oscillator
- DDL 3.33
- CGEM 5.06
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.